125535 -

Published in on April 4, 2019, this research investigates a novel approach to treating solid tumors by leveraging the properties of sickle red blood cells.

The number primarily refers to a medical research paper titled "Exogenous sickle erythrocytes combined with vascular disruption trigger disseminated tumor vaso-occlusion and lung tumor regression" . Article Overview: JCI Insight 125535 125535

: "The impact of public eco-concern on urban eco-efficiency: A dual perspective analysis of net effect and configuration." Authors : Chao Wang and Jinbo Jiang. Published in on April 4, 2019, this research

: The study uses "exogenous" (externally introduced) sickle red blood cells in combination with a vascular-disrupting agent to target the blood supply of tumors. : The study uses "exogenous" (externally introduced) sickle

: The researchers found that this combination triggers a "vaso-occlusive" event—essentially a controlled blockage of the blood vessels feeding the tumor—which leads to tumor cell death.